In April 2024, Protara Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.81 USD | -3.10% | +0.36% | +49.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.86% | 57.86M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- TARA Stock
- News Protara Therapeutics, Inc.
- Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors